Cargando…

Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia

ABSTRACT: BACKGROUND: This study aimed to investigate the clinical significance of contrast enhanced ultrasound (CEUS) in diagnosis of benign prostatic hyperplasia (BPH) through comparing CEUS parameters between BPH and normal person. METHODS: A retrospective study of sixty BPH patients (aged 73.5 ±...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jingfang, Yin, Xiaohua, Xu, Rong, Wang, Yingchun, Jin, Lin, Gao, Weiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108000/ https://www.ncbi.nlm.nih.gov/pubmed/24986664 http://dx.doi.org/10.1186/1746-1596-9-133

Ejemplares similares

Retraction Note: Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia
por: Shi, Jingfang, et al.
Publicado: (2015)

Depressive symptoms in patients diagnosed with benign prostatic hyperplasia
por: Pietrzyk, Barbara, et al.
Publicado: (2015)

Benign Prostatic Hyperplasia
Publicado: (2015)

Current Applications of Artificial Intelligence in Benign Prostatic Hyperplasia
por: Shah, Milap, et al.
Publicado: (2022)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Application of contrast-enhanced ultrasound in minimally invasive ablation of benign thyroid nodules
por: Cao, Jiaying, et al.
Publicado: (2022)

Assessment of the utility of platelet indices to diagnose clinical benign prostatic hyperplasia in dogs
por: Hosseinpour, Hediyeh, et al.
Publicado: (2022)

Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
por: Zhou, Jing, et al.
Publicado: (2022)

Metabolic syndrome and benign prostatic hyperplasia: An update
por: Ngai, Ho-Yin, et al.
Publicado: (2017)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Focal nodular hyperplasia: with a focus on contrast enhanced ultrasound
por: Kang, Ho Suk, et al.
Publicado: (2010)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
por: Dun, Rong-liang, et al.
Publicado: (2022)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Benign prostatic hyperplasia: An overview of existing treatment
por: Dhingra, Neelima, et al.
Publicado: (2011)

Therapeutic options in the treatment of benign prostatic hyperplasia
por: Sandhu, Jaspreet S
Publicado: (2009)

Unsolved Issues in Managing Benign Prostatic Hyperplasia
por: Oh, Seung-June
Publicado: (2013)

Recent advances in treatment for Benign Prostatic Hyperplasia
por: van Rij, Simon, et al.
Publicado: (2015)

Diagnosis and treatment of benign prostate hyperplasia in Asia
por: Foo, Keong Tatt
Publicado: (2015)

Chromosomal aberrations in benign prostatic hyperplasia patients
por: Altok, Muammer, et al.
Publicado: (2016)

Fibronectin Pattern in Benign Hyperplasia and Cancer of the Prostate
por: Janković, Miroslava M., et al.
Publicado: (2008)

Genetic alterations in benign prostatic hyperplasia patients
por: Mohamed, Hanaa Mahmoud, et al.
Publicado: (2017)

Commentary on “Solving the benign prostatic hyperplasia puzzle”
por: Thomas, Dominique, et al.
Publicado: (2018)

Recent advances in prostatectomy for benign prostatic hyperplasia
por: Te, Alexis E.
Publicado: (2019)

Treatment of Benign Prostatic Hyperplasia by Natural Drugs
por: Csikós, Eszter, et al.
Publicado: (2021)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7lse684sbd8ug02bogdorttp4l